Back to search

Institutional Repository of Vilnius University

Long-Term results (10 and more years) after by-pass roux y operation for the treatment of obesity /

Abstract

dc:description

Purpose: Roux-en-Y Gastric Bypass (RYGB) is the second most commonly performed bariatric surgery and has demonstrated significant postoperative weight loss and improvement in obesity-related comorbidities. However, long-term results of 10 years or more are insufficiently documented. This systematic review aims to analyze the outcomes of studies and provide an up-to-date perspective on the successes and challenges of RYGB. Methods: The comprehensive literature review followed the 2020 PRISMA guidelines using PubMed, Cochrane Controlled Trials Register, and ScienceDirect databases. It includes publications from the years 2014- 2024. The research was conducted from January 2024 to May 2024 and included only articles with full texts available in English. Results: Of the initial 313 articles, 257 were excluded for not fulfilling the predetermined inclusion criteria. 40 full-text articles were assessed for eligibility, with 29 articles meeting the inclusion criteria. In the included studies, 11,435 patients underwent RYGB as the primary surgery procedure; therefrom, 4,995 patients (44%) completed the 10-year follow-up. After ten years, the BMI decreased to 35.9 (±4.1) kg/m² from an initial average of 49.1 (±3.4) kg/m². The % TWL, %EWL, and %EBMIL results were 28.9 (±3.8)%, 60.9 (±7.6)%, and 57.8 (±9.8)%, respectively, ten years post-RYGB. Comparing the 2-year and 10-year results, a decrease in % TWL, %EWL, and %EBMIL values by -6.75%, -14.23%, and -18.19% was revealed, along with an increase in the BMI of 19.04%, indicating a gradual reduction in weight loss in the long term. These differences in weight loss values between the 2-year and 10-year time mark were statistically significant. A remission of type 2 diabetes was noted in 61.9% of patients 10 years post-RYGB. Arterial hypertension, dyslipidemia, obstructive sleep apnea, and gastroesophageal reflux disease displayed remission rates of 49.5%, 61.3%, 66.1%, and 54.4%, respectively. Conclusion: This systematic review confirms the highly effective outcomes of RYGB surgery, including the success in reducing specific weight loss values and improving the remission rates of obesity-related comorbidities. However, low follow-up rates and the lack of unity in the definition of RYGB success make it challenging for the reviewer to evaluate the overall effectiveness.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Rach, Paulina-Doreen,

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
eng

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Rach, Paulina-Doreen,. Long-Term results (10 and more years) after by-pass roux y operation for the treatment of obesity /. Institutional Repository of Vilnius University, 2025. https://repository.vu.lt/VU:ELABAETD238872533&prefLang=en_US